Cargando…

Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19

Detalles Bibliográficos
Autores principales:	Shahridan Faiez, Tasnim, Singanayagam, Aran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875899/ https://www.ncbi.nlm.nih.gov/pubmed/35452367 http://dx.doi.org/10.1164/rccm.202203-0526ED

Ejemplares similares

Asthma and viruses: A focus on rhinoviruses and SARS-CoV-2
por: Padayachee, Yorissa, et al.
Publicado: (2021)

When It Comes to COVID-19, Inflammation Is All the RAGE
por: Katsoulis, Orestis, et al.
Publicado: (2023)

Metagenomic Characterization of the Respiratory Microbiome. A Pièce de Résistance
por: Ritchie, Andrew I., et al.
Publicado: (2020)

Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
por: Peñaloza, Hernán F., et al.
Publicado: (2021)

Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
por: Martínez-Urbistondo, María, et al.
Publicado: (2021)

Lymphopenia: A useful predictor of COVID-19 disease severity and mortality
por: Toori, Kaleem Ullah, et al.
Publicado: (2021)

Prognostic importance of lymphopenia in West Nile encephalitis
por: Cunha, Burke A., et al.
Publicado: (2004)

The function of myeloid-derived suppressor cells in COVID-19 lymphopenia
por: Li, Taosan, et al.
Publicado: (2022)

Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
por: Tan, Li, et al.
Publicado: (2020)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Possible Mechanisms of Lymphopenia in Severe Tuberculosis
por: Li, Fei, et al.
Publicado: (2023)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Why asthma might surprisingly protect against poor outcomes in COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Abnormal Thyroid Function Is Associated With Lymphopenia in Bacterial Sepsis and COVID-19
por: Grondman, Inge, et al.
Publicado: (2021)

Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
por: Tan, Li, et al.
Publicado: (2020)

COVID-19, ECMO, and lymphopenia: a word of caution
por: Henry, Brandon Michael
Publicado: (2020)

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis
por: Huang, Ian, et al.
Publicado: (2020)

Hyperglycemia associated with lymphopenia and disease severity of COVID-19 in type 2 diabetes mellitus
por: Cheng, Yangyang, et al.
Publicado: (2021)

Lymphopenia and IgG2 subclass deficiency in patients with severe COVID-19 pneumonia
por: Taban, E M, et al.
Publicado: (2021)

Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis
por: Henry, Brandon Michael, et al.
Publicado: (2020)

Is lymphopenia different between SARS and COVID‐19 patients?
por: Yan, Shaomin, et al.
Publicado: (2021)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003)

High prevalence of infections in non-COVID-19 patients admitted to the Emergency Department with severe lymphopenia
por: Baïsse, Arthur, et al.
Publicado: (2022)

Is leukopenia and lymphopenia a characteristic feature of COVID-19 in children?
por: Bari, Attia, et al.
Publicado: (2021)

Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity
por: Huang, Glen, et al.
Publicado: (2020)

Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study
por: Liu, Jiheng, et al.
Publicado: (2020)

Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
por: Lo Presti, Elena, et al.
Publicado: (2021)

Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact
por: Zhang, Sifan, et al.
Publicado: (2021)

P1602: THE ASSESSMENT OF LYMPHOPENIA AS RISK FACTOR FOR UNFAVORABLE EVOLUTION OF PATIENTS WITH SEVERE FORM OF COVID 19
por: Popov, V., et al.
Publicado: (2022)

Staring down the barrel of COVID-19
por: Suryawanshi, Milind Prasannakumar, et al.
Publicado: (2020)

Lymphopenia and autoimmune diseases
por: Schulze-Koops, Hendrik
Publicado: (2004)

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
por: Zhao, Qianwen, et al.
Publicado: (2020)

Lymphopenia in hospitalized patients and its relationship with severity of illness and mortality
por: Andreu-Ballester, Juan Carlos, et al.
Publicado: (2021)

COVID-19-vaccine/mycophenolate: Cytomegalovirus infection and lymphopenia: case report
Publicado: (2022)

Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia
por: Barbati, Cristiana, et al.
Publicado: (2022)

IL-6 drives T cell death to participate in lymphopenia in COVID-19
por: Zhou, Xiaoqi, et al.
Publicado: (2022)

COVID-19 from the land “Down Under” in an upside-down world: an Australian perspective
por: Rang, Catherine, et al.
Publicado: (2020)

Fingolimod: Lymphopenia and COVID-19 infection complicated by pneumonia: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8v65sg2e7a88dcong0sgspptc